Management Change/Compensation (Form 8-K)

On July 14, 2026, each of David Johnson and Nino Pionati voluntarily resigned from their respective positions as members of the Board of Directors (the "Board") of ENvue Medical, Inc. (the "Company"). Messers. Johnson and Pionati's resignations did not resign as a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

In addition, on July 14, 2026, the remaining members of the Board appointed each of Zvi Joseph and Lior Buchman as members of the Board to fill the vacancies created by the resignations of Messers. Johnson and Pionati. Mr. Joseph was appointed to serve on the Company's Audit Committee and Nominating and Corporate Governance Committee. Mr. Buchman was appointed to serve on the Company's Audit Committee and Compensation Committee and will serve as the Chairman of the Compensation Committee. In addition, Zeev Rotstein, M.D., an existing member of the Board, was appointed to Chair of the Nominating and Corporate Governance Committee.

In addition, Prof. Rotstein was appointed to serve as the new Chairman of the Board.

As remuneration for their service as directors, Messrs. Joseph and Buchman will receive the same fees as the Company's other non-executive directors. There is no arrangement or understanding between Messrs. Joseph and Buchman and any other person pursuant to which they were elected as directors, there are no transactions in which Messrs. Joseph and Buchman have an interest requiring disclosure under Item 404(a) of Regulation S-K.